Get started
Author

Armando Patrizio

Observed names: A. Patrizio, A.� Patrizio, Armando� Patrizio
ORCID: 0000-0003-1090-4794
Observed ORCID: 0000-0003-1090-4794
OpenAlex ID: A5001361998
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
2020 · Alessandro Antonelli, Silvia Martina Ferrari, et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 297
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
2019 · Silvia Martina Ferrari, Poupak Fallahi, et al. · International Journal of Molecular Sciences · 277
PDF
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy
2020 · Alessandro Antonelli, Poupak Fallahi, et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 218
Novel treatments for anaplastic thyroid carcinoma
2020 · Silvia Martina Ferrari, Giusy Elia, et al. · Gland Surgery · 122
Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies
2019 · Silvia Martina Ferrari, Poupak Fallahi, et al. · International Journal of Molecular Sciences · 114
PDF
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination
2021 · Armando Patrizio, Silvia Martina Ferrari, et al. · Journal of Autoimmunity · 89
PDF
Chemokines in thyroid autoimmunity
2023 · Silvia Martina Ferrari, Sabrina Rosaria Paparo, et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 82
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
2018 · Silvia Ferrari, Guido Bocci, et al. · Oncology Reports · 60
PDF
Hypothyroidism and metabolic cardiovascular disease
2024 · Armando Patrizio, Silvia Martina Ferrari, et al. · Frontiers in Endocrinology · 59
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
2021 · Poupak Fallahi, Silvia Martina Ferrari, et al. · Frontiers in Endocrinology · 55
PDF
Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
2019 · Silvia Martina Ferrari, Poupak Fallahi, et al. · Journal of Immunology Research · 52
PDF
Chemokines in hyperthyroidism
2019 · Silvia Martina Ferrari, Ilaria Ruffilli, et al. · Journal of Clinical & Translational Endocrinology · 51
Molecular features of aggressive thyroid cancer
2022 · Giusy Elia, Armando Patrizio, et al. · Frontiers in Oncology · 45
PDF
Thyroid Autoimmunity and SARS-CoV-2 Infection
2023 · Poupak Fallahi, Giusy Elia, et al. · Journal of Clinical Medicine · 44
PDF
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
2018 · Silvia Ferrari, Guido Bocci, et al. · Oncology Reports · 33
PDF
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
2020 · Poupak Fallahi, Silvia Martina Ferrari, et al. · Seminars in Cancer Biology · 32
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
2018 · Silvia Martina Ferrari, Concettina La Motta, et al. · Frontiers in Endocrinology · 29
PDF
Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies
2020 · Salvatore Benvenga, Silvia Martina Ferrari, et al. · Nutrients · 28
PDF
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
2019 · Poupak Fallahi, Silvia Martina Ferrari, et al. · Cancer Management and Research · 27
PDF
Myoinositol in Autoimmune Thyroiditis
2022 · Sabrina Rosaria Paparo, Silvia Martina Ferrari, et al. · Frontiers in Endocrinology · 24
PDF
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review
2023 · Poupak Fallahi, Armando Patrizio, et al. · Current Oncology · 23
PDF
Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
2018 · Poupak Fallahi, Silvia Martina Ferrari, et al. · Laryngoscope Investigative Otolaryngology · 23
PDF
Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
2022 · Armando Patrizio, Silvia Martina Ferrari, et al. · Vaccines · 22
PDF
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
2022 · Francesca Ragusa, Silvia Martina Ferrari, et al. · International Journal of Molecular Sciences · 21
PDF
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination
2022 · Armando Patrizio, Silvia Martina Ferrari, et al. · Autoimmunity Reviews · 21
PDF
Works count: 70
Citation count: 2,037
H-index: 22
I10-index: 33
Year
Topic
Type